Publikationer – Magnus Lindskogs grupp

Publikationer i DiVA (Lindskog)

Publikationer i DiVA (Sandelin)

Ett urval av våra publikationer:

Werlenius K, Kinhult S, Skeidsvoll Solheim T, Magelssen H, Löfgren D, Mudaisi M, Hylin S, Bartek J Jr, Strandéus M, Lindskog M, MD, Rashid HB, Carstam L, GulatiS, Solheim O, Bartek J, Salvesen Ö, MSc, Store Jakola A. Effect of disulfiram and copper plus chemotherapy vs chemotherapy alone on survival in patients with recurrent glioblastoma: A randomized clinical trial. Accepted for publication in JAMA Network Open, Feb 2023.
Tsakonas G, Koulouris A, Kazmierczak D, Botling J, Ortiz-Villalon C, Nord H, Lindskog M, Sandelin M, Micke P, Hydbring P, Ekman S. Matched Analyses of Brain Metastases versus Primary Non-Small Cell Lung Cancer Reveal a Unique microRNA Signature. Int J Mol Sci 2022, 24(1):193.
Lindskog M, Schultz T, Strang P. Acute healthcare utilization in end-of-life among Swedish brain tumor patients - a population based register study. BMC Palliat Care. 2022, 21(1):133.
Lindskog M, Laurell A, Kjellman A, Melichar B, Rey PM, Zieliński H, Villacampa F, Bigot P, Zoltan B, Parikh O, Alba DV, Jellvert Å, Flaskó T, Gallardo E, Caparrós MJR, Purkalne G, Suenaert P, Karlsson-Parra A, Ljungberg B. Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study. Eur Urol Open Sci. 2022, 40:38-45.
Stenman M, Benmakhlouf H, Wersäll P, Johnstone P, Hatiboglu MA, Mayer-da-Silva J, Harmenberg U, Lindskog M, Sinclair G. Metastatic renal cell carcinoma to the brain: optimizing patient selection for gamma knife radiosurgery. Acta Neurochir (Wien). 2021, 163(2):333-342.
Tsakonas G, Lewensohn R, Botling J, Ortiz-Villalon C, Micke P, Friesland S, Nord H, Lindskog M, Sandelin M, Hydbring P, Ekman S. An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non-small-cell lung cancer Eur J Cancer. 2020, 132:24-34.
Elmstedt S, Mogensen H, Hallmans DE, Tavelin B, Lundström S, Lindskog M. Cancer patients hospitalised in the last week of life risk insufficient care quality - a population-based study from the Swedish Register of Palliative CareActa Oncol. 2019 Apr;58(4):432-438. doi: 10.1080/0284186X.2018.1556802.
Stenman M, Staehler M, Szabados B, Sandström P, Laurell A, Lindskog M, Harmenberg U. Metastatic papillary renal cell carcinoma in the era of targeted therapy - a retrospective study from three European academic centres. Acta Oncol. 2019, 58(3):306-312.
Stenman M, Sinclair G, Paavola P, Wersäll P, Harmenberg U, Lindskog M. Overall survival after stereotactic radiotherapy or surgical metastasectomy in oligometastatic renal cell carcinoma patients treated at two Swedish centres 2005-2014.Radiother Oncol. 2018, 127(3):501-506.
Lindskog M, Wahlgren T, Sandin R, Kowalski J, Jakobsson M, Lundstam S, Ljungberg B, Harmenberg U. Overall survival in Swedish patients with renal cell carcinoma treated in the period 2002 to 2012: Update of the RENCOMP study with subgroup analysis of the synchronous metastatic and elderly populations. Urol Oncol. 2017, 35(9):541.e15-541.e22.